These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21396436)

  • 1. Effects of a nanocomposite containing Orbignya speciosa lipophilic extract on Benign Prostatic Hyperplasia.
    de Souza PA; Palumbo A; Alves LM; de Souza VP; Cabral LM; Fernandes PD; Takiya CM; Menezes FS; Nasciutti LE
    J Ethnopharmacol; 2011 Apr; 135(1):135-46. PubMed ID: 21396436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethnopharmacological use of babassu (Orbignya phalerata Mart) in communities of babassu nut breakers in Maranhão, Brazil.
    Souza MH; Monteiro CA; Figueredo PM; Nascimento FR; Guerra RN
    J Ethnopharmacol; 2011 Jan; 133(1):1-5. PubMed ID: 20832463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pygeum africanum extract inhibits proliferation of human cultured prostatic fibroblasts and myofibroblasts.
    Boulbès D; Soustelle L; Costa P; Haddoum M; Bali JP; Hollande F; Magous R
    BJU Int; 2006 Nov; 98(5):1106-13. PubMed ID: 17034612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia.
    Krishnamoorthi R; Ganapathy A A; Hari Priya VM; Kumaran A
    J Ethnopharmacol; 2024 Aug; 330():118207. PubMed ID: 38636573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: sexual function.
    Lowe FC
    BJU Int; 2005 Jun; 95 Suppl 4():12-8. PubMed ID: 15871731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of crude polysaccharides from Semen vaccariae on benign prostatic hyperplasia in mice.
    Zhang H; Jing Y; Wu G
    J Ethnopharmacol; 2013 Jan; 145(2):667-9. PubMed ID: 23202245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rice Hull Extract Suppresses Benign Prostate Hyperplasia by Decreasing Inflammation and Regulating Cell Proliferation in Rats.
    Kim CY; Chung KS; Cheon SY; Lee JH; Park YB; An HJ
    J Med Food; 2016 Aug; 19(8):746-54. PubMed ID: 27441629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Vitex agnus-castus extract inhibits cell growth and induces apoptosis in prostate epithelial cell lines.
    Weisskopf M; Schaffner W; Jundt G; Sulser T; Wyler S; Tullberg-Reinert H
    Planta Med; 2005 Oct; 71(10):910-6. PubMed ID: 16254821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician perceptions of sexual dysfunction related to benign prostatic hyperplasia (BPH) symptoms and sexual side effects related to BPH medications.
    Seftel A; Rosen R; Kuritzky L
    Int J Impot Res; 2007; 19(4):386-92. PubMed ID: 17377613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative and apoptotic effects of the herbal agent Pygeum africanum on cultured prostate stromal cells from patients with benign prostatic hyperplasia (BPH).
    Quiles MT; Arbós MA; Fraga A; de Torres IM; Reventós J; Morote J
    Prostate; 2010 Jul; 70(10):1044-53. PubMed ID: 20503393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician.
    Chapple CR
    BJU Int; 2004 Sep; 94(5):738-44. PubMed ID: 15329091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Red clover isoflavones inhibit the proliferation and promote the apoptosis of benign prostatic hyperplasia stromal cells].
    Chen MY; Yan SC; Yin CP; Ye L; Zhang MK; Yang J; Liu JH
    Zhonghua Nan Ke Xue; 2010 Jan; 16(1):34-9. PubMed ID: 20180402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol Extract of
    Park E; Lee MY; Seo CS; Jang JH; Kim YU; Shin HK
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the relationship between sexual dysfunction and lower urinary tract symptoms/benign prostatic hyperplasia.
    Rosen RC
    Curr Opin Urol; 2006 Jan; 16(1):11-9. PubMed ID: 16385195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
    Sharma M; Chadha R; Dhingra N
    Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-adrenoceptors are a common denominator in the pathophysiology of erectile function and BPH/LUTS--implications for clinical practice.
    Yassin A; Saad F; Hoesl CE; Traish AM; Hammadeh M; Shabsigh R
    Andrologia; 2006 Feb; 38(1):1-12. PubMed ID: 16420236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticholinergic therapy for lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gallegos PJ; Frazee LA
    Pharmacotherapy; 2008 Mar; 28(3):356-65. PubMed ID: 18294115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.